home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Understanding Cancer Spread

  March, 21 2007 8:33
your information resource in human molecular genetics
A signalling pathway that enhances the formation of metastases in a mouse model of prostate cancer has been identified. The discovery, reported online in Nature, should aid our understanding of how cancer spreads.

Michael Karin and colleagues discovered that the pathway is activated by a protein that is likely to be expressed by tumour inflammatory cells. The protein is a ligand and when it binds to its receptor, called receptor activator of nuclear factor kappa-B (RANK), it triggers a chain reaction. A key kinase in the nuclear factor kappa-B signalling pathway is activated to function in the cell's nucleus and, this in turn, represses the transcription of a known metastasis suppressor called Maspin. The end result, in their mouse model at least, is that prostate cancer cells spread.

The results suggest that RANK may be a general promoter of metastasis. Importantly, its activating ligand is vastly upregulated in the late stages of prostate cancer, which may explain why metastasis is so common at that stage in the disease.

Author contact:

Michael Karin (University of California, La Jolla, CA, USA)
E-mail: karinoffice@ucsd.edu

Abstract available online.

(C) Nature press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.